News
Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...
A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...
New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...
Regeneron Pharmaceuticals said on Monday its experimental weight-loss drug combination helped preserve muscle mass in a ...
American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results